These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 16199074

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif.
    Schubert U, Henklein P, Boldyreff B, Wingender E, Strebel K, Porstmann T.
    J Mol Biol; 1994 Feb 11; 236(1):16-25. PubMed ID: 8107101
    [Abstract] [Full Text] [Related]

  • 23. Innate differences between simian-human immunodeficiency virus (SHIV)(KU-2)-infected rhesus and pig-tailed macaques in development of neurological disease.
    Buch SJ, Villinger F, Pinson D, Hou Y, Adany I, Li Z, Dalal R, Raghavan R, Kumar A, Narayan O.
    Virology; 2002 Mar 30; 295(1):54-62. PubMed ID: 12033765
    [Abstract] [Full Text] [Related]

  • 24. A cell-free stock of simian-human immunodeficiency virus that causes AIDS in pig-tailed macaques has a limited number of amino acid substitutions in both SIVmac and HIV-1 regions of the genome and has offered cytotropism.
    Stephens EB, Mukherjee S, Sahni M, Zhuge W, Raghavan R, Singh DK, Leung K, Atkinson B, Li Z, Joag SV, Liu ZQ, Narayan O.
    Virology; 1997 May 12; 231(2):313-21. PubMed ID: 9168893
    [Abstract] [Full Text] [Related]

  • 25. Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking Motif.
    Breed MW, Elser SE, Torben W, Jordan AP, Aye PP, Midkiff C, Schiro F, Sugimoto C, Alvarez-Hernandez X, Blair RV, Somasunderam A, Utay NS, Kuroda MJ, Pahar B, Wiseman RW, O'Connor DH, LaBranche CC, Montefiori DC, Marsh M, Li Y, Piatak M, Lifson JD, Keele BF, Fultz PN, Lackner AA, Hoxie JA.
    J Virol; 2015 Oct 12; 89(20):10156-75. PubMed ID: 26223646
    [Abstract] [Full Text] [Related]

  • 26. Human immunodeficiency virus type 1 VPU protein affects Sindbis virus glycoprotein processing and enhances membrane permeabilization.
    González ME, Carrasco L.
    Virology; 2001 Jan 05; 279(1):201-9. PubMed ID: 11145902
    [Abstract] [Full Text] [Related]

  • 27. Some human immunodeficiency virus type 1 Vpu proteins are able to antagonize macaque BST-2 in vitro and in vivo: Vpu-negative simian-human immunodeficiency viruses are attenuated in vivo.
    Shingai M, Yoshida T, Martin MA, Strebel K.
    J Virol; 2011 Oct 05; 85(19):9708-15. PubMed ID: 21775449
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects of Vpu expression on Xenopus oocyte membrane conductance.
    Coady MJ, Daniel NG, Tiganos E, Allain B, Friborg J, Lapointe JY, Cohen EA.
    Virology; 1998 Apr 25; 244(1):39-49. PubMed ID: 9581776
    [Abstract] [Full Text] [Related]

  • 30. Importance of the intracytoplasmic domain of the simian immunodeficiency virus (SIV) envelope glycoprotein for pathogenesis.
    Luciw PA, Shaw KE, Shacklett BL, Marthas ML.
    Virology; 1998 Dec 05; 252(1):9-16. PubMed ID: 9875311
    [Abstract] [Full Text] [Related]

  • 31. Plateau levels of viremia correlate with the degree of CD4+-T-cell loss in simian immunodeficiency virus SIVagm-infected pigtailed macaques: variable pathogenicity of natural SIVagm isolates.
    Goldstein S, Ourmanov I, Brown CR, Plishka R, Buckler-White A, Byrum R, Hirsch VM.
    J Virol; 2005 Apr 05; 79(8):5153-62. PubMed ID: 15795299
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein.
    Friborg J, Ladha A, Göttlinger H, Haseltine WA, Cohen EA.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan 01; 8(1):10-22. PubMed ID: 8548340
    [Abstract] [Full Text] [Related]

  • 34. A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo.
    Pöhlmann S, Münch J, Aziz S, Reeves JD, Otto C, Leslie GJ, Hofmann H, Puffer BA, Baribaud F, Marzi A, Gramberg T, Chen Z, Stolte N, Haaft PT, Heeney JL, Stahl-Hennig C, Mätz-Rensing K, Schneider T, Doms RW, Kirchhoff F.
    Virology; 2007 Apr 10; 360(2):275-85. PubMed ID: 17126374
    [Abstract] [Full Text] [Related]

  • 35. Conformational changes induced by a single amino acid substitution in the trans-membrane domain of Vpu: implications for HIV-1 susceptibility to channel blocking drugs.
    Park SH, Opella SJ.
    Protein Sci; 2007 Oct 10; 16(10):2205-15. PubMed ID: 17766368
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Properties of a chimeric simian-human immunodeficiency virus expressing an hybrid HIV-1 Nef/SIVmac Nef protein.
    Bertsch C, Cluet D, Beyer C, Gloeckler L, Cecile A, Gut JP, Aubertin AM.
    Arch Virol; 2002 Oct 10; 147(10):1963-75. PubMed ID: 12376757
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The human immunodeficiency virus type 1 Vpu protein enhances membrane permeability.
    González ME, Carrasco L.
    Biochemistry; 1998 Sep 29; 37(39):13710-9. PubMed ID: 9753459
    [Abstract] [Full Text] [Related]

  • 40. Interaction between the cytoplasmic domains of HIV-1 Vpu and CD4: role of Vpu residues involved in CD4 interaction and in vitro CD4 degradation.
    Margottin F, Benichou S, Durand H, Richard V, Liu LX, Gomas E, Benarous R.
    Virology; 1996 Sep 15; 223(2):381-6. PubMed ID: 8806575
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.